欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4404/003
药品名称LENALIDOMIDE/ANABIOSIS
活性成分
    • lenalidomide hydrochloride 15.0 mg
剂型Capsule, hard
上市许可持有人ANABIOSIS PC 1 Amaliados str., Kifissia 14564 Athens Greece
参考成员国 - 产品名称Netherlands (NL)
Lenalidomide/Anabiosis 15 mg harde capsules
互认成员国 - 产品名称
    • Greece (GR)
    • Cyprus (CY)
      Lenalidomide Anabiosis 15mg hard capsules
许可日期2019/10/24
最近更新日期2024/12/05
药物ATC编码
    • L04AX04 lenalidomide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase